drugset / Trial / NCT01278602
R-ESHAP Followed by Autologous Transplantation for Refractory or Relapsed Diffused Large B-cell Lymphoma
NaSingle-groupOpen-labelTreatment
Summary
The aim of study is to prove R-ESHAP regimen followed by autologous stem cell transplantation as salvage treatment in patients with refractory or relapsed diffuse large B-cell lymphoma is effective.
Timeline
- Start
- 2010-12
- Primary completion
- 2013-12
- Completion
- 2014-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | 25 mg/m2 | — |
| Subject | Cytarabine | Small molecule | 2000 mg/m2 | — |
| Subject | Etoposide | Small molecule | 40 mg/m2 | — |
| Subject | Meththylprednisolone | Unknown | 500 mg | Intravenous |
| Subject | Rituximab | Monoclonal antibody | 375 mg/m2 | — |